Potential predictors of surgical evacuation following early medical abortion: a prospective study

Ritu Bansal; Naimaa K. Chaudhary; Asha Sharma

doi:10.18203/2320-1770.ijrcog20212666

Authors

Ritu Bansal Department of Obstetrics and Gynaecology, St. Stephen’s Hospital, Delhi, India
Naimaa K. Chaudhary Department of Obstetrics and Gynaecology, St. Stephen’s Hospital, Delhi, India
Asha Sharma Department of Obstetrics and Gynaecology, St. Stephen’s Hospital, Delhi, India

DOI:

https://doi.org/10.18203/2320-1770.ijrcog20212666

Keywords:

Missed abortion, Surgical evacuation, Misoprostol

Abstract

Background: Medical management is the safer, effective and more convenient method for the management of missed abortion. Owing to the risk and complications, medical management is offered to all the women presenting with missed abortions. Yet after all possible efforts a large number of patients land up into surgical evacuation. This study is conducted for the in-depth analysis of the patient's presenting complaints and their risk factors to establish the correlation of these factors with failed medical abortion. This would help in the establishment of easily identifiable subgroups for whom medical management would be a success.

Methods: This is a prospective observational study conducted at St. Stephen’s hospital Delhi during September 2019-June 2020. 55 women with missed abortion attending the gynaecological clinic and emergency, were recruited based on inclusion and exclusion criteria. After taking informed and written consent, all cases were administered misoprostol by vaginal route for medical management. Patients were followed up for 24 hours and looked for the outcome.

Results: We found that multiparity, advanced gestational age and previous caesarean deliveries were the predictors of uterine evacuation following failed medical management. Higher chances of complete abortion were seen among multiparous and among the patients who had bleeding at the time of presentation. Failure of medical management was seen in around 70% cases with more than 9 weeks gestational age. Lesser side effects are observed with 400 mcg misoprostol dosing.

Conclusions: Nulliparous patients and the patients presenting with bleeding at the time of presentation had more complete abortion. Multiparity and previous caesarean delivery is associated with failed medical management. After studying the potential risk factors, every patient can be counselled about the chances of completion of medical management.

Metrics

Metrics Loading ...

References

National Institute of Health and Care excellence. Ectopic pregnancy and miscarriage: diagnosis and initial management. National Institute of Health and Care excellence guideline. 2019;126:1-32

Wilcox AJ, Weinberg CR, O'Connor JF, Baird DD, Schlatterer JP, Canfield RE et al. Incidence of early loss of pregnancy. N Engl J Med. 1988;319(4):189-94.

Wang X, Chen C, Wang L, Chen D, Guang W, French J. Conception, early pregnancy loss, and time to clinical pregnancy: a population-based prospective study. Fertil Steril. 2003;79(3):577-84.

Zinaman MJ, Clegg ED, Brown CC, O’Connor J, Selevan SG. Estimates of human fertility and pregnancy loss. Fertil Steril. 1996;65(3):503-9.

Zhang J, Gilles JM, Barnhart K, Creinin MD, Westhoff C, Frederick MM et al. A comparison of medical management with misoprostol and surgical management for early pregnancy failure. N Engl J Med. 2005;353(8):761-9.

Reeves MF, Monmaney JA, Creinin MD. Predictors of uterine evacuation following early medical abortion with mifepristone and misoprostol. Contraception. 2016;93(2):119-25.

Creinin MD, Huang X, Westhoff C, Barnhart K, Gilles JM, Zhang J et al. Factors related to successful misoprostol treatment for early pregnancy failure. Obstet Gynecol. 2006;107(4):901-7.

Moore KL. The Developing Human: Clinically Oriented Embryology. Philadelphia, WB Saunders. 1977;2.

Stephenson MD, Awartani KA, Robinson WP. Cytogenetic analysis of miscarriages from couples with recurrent miscarriage: a case-control study. Hum Reprod Oxf Engl. 2002;17(2):446-51.

Practice Committee of the American Society for Reproductive Medicine. Evaluation and treatment of recurrent pregnancy loss: a committee opinion. Fertil Steril. 2012;98(5):1103-11.

Barnhart KT. Early pregnancy failure: beware of the pitfalls of modern management. Fertil Steril. 2012;98(5):1061-5.

Doubilet PM, Benson CB, Bourne T, Blaivas M. Society of Radiologists in Ultrasound Multispecialty Panel on Early First Trimester Diagnosis of Miscarriage and Exclusion of a Viable Intrauterine Pregnancy. Diagnostic criteria for nonviable pregnancy early in the first trimester. Ultrasound Q. 2014;30(1):3-9.

Arias F, Bhide AG, Arulkumaran S, Damania K, Daftary SN. Arias' Practical Guide to High-Risk Pregnancy and Delivery: A South Asian Perspective. Elsevier India. 2019;25.

Early pregnancy loss. ACOG Practice Bulletin. American College of Obstetricians and Gynecologists. Obstet Gynecol. 2018;132:e197-207.

Ahmad B, Shekhar C, Jindal S, Gupta S. Misoprostol for induction of labour: a comparative study of various routes of administration. Int J Reprod Contracept Obstet Gynecol. 2017;6(10):4583.

Zieman M, Fong SK, Benowitz NL, Banskter D, Darney PD. Absorption kinetics of misoprostol with oral or vaginal administration. Obstet Gynecol. 1997;90(1):88-92.

Ashok PW, Penney GC, Flett GM, Templeton A. An effective regimen for early medical abortion: a report of 2000 consecutive cases. Hum Reprod Oxf Engl. 1998;13(1O):2962-5.

Ashok PW, Templeton A, Wagaarachchi PT, Flett GMM. Factors affecting the outcome of early medical abortion: a review of 4132 consecutive cases. Int J Obstetr Gynaecol. 2002;109(11):1281-9.

Spitz IM, Bardin CW, Benton L, Robbins A. Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med. 1998;338(18):1241-7.

Behnamfar F, Mahdian M, Rahimi F, Samimi M. Misoprostol Abortion: Ultrasonography versus Beta-hCG Testing for Verification of Effectiveness. Pak J Med Sci. 2013;29(6):1367-70.

Haimov-Kochman R, Arbel R, Sciaky-Tamir Y, Brzezinski A, Laufer N, Yagel S. Risk factors for unsuccessful medical abortion with mifepristone and misoprostol. Acta Obstet Gynecol Scand. 2007;86(4):462-6.

Chien L-W, Liu W-M, Tzeng C-R, Au H-K. Effect of previous live birth and prior route of delivery on the outcome of early medical abortion. Obstet Gynecol. 2009;113(3):669-74.

Allam NE, Mohamed TM, Wahba SM. Designing a Scoring System for Predicting Effectiveness of Misoprostol-Alone Regimen Used in Early Pregnancy Failure. 2016;3:10.

Karmyshev AO, Ryskel’dieva VT, Sorokin AA. Efficiency of various methods for termination of nondeveloping early pregnancy: A randomized clinical trial. Ross Vestn Akushera-Ginekol. 2017;17(2):64.

refumo F, Ganapathy R, Thilaganathan B, Sebire NJ. Influence of parity on first trimester endovascular trophoblast invasion. Fertil Steril. 2006;85(4):1032-6.

Niinimäki M, Martikainen H, Talvensaari-Mattila A. Increased risk for medical abortion failure for multiparous women. Int J Gynaecol Obstet Off Organ Int Fed Gynaecol Obstet. 2004;87(2):174-5.

Meaidi A, Friedrich S, Gerds TA, Lidegaard O. Risk factors for surgical intervention of early medical abortion. Am J Obstet Gynecol. 2019;220(5):478.e1-15.

Bartley J, Tong S, Everington D, Baird DT. Parity is a major determinant of success rate in medical abortion: a retrospective analysis of 3161 consecutive cases of early medical abortion treated with reduced doses of mifepristone and vaginal gemeprost. Contraception. 2000;62(6):297-303.

Rorbye C. Prediction of late failure after medical abortion from serial -hCG measurements and ultrasonography. Hum Reprod. 2004;19(1):85-9.

Aldrich T, Winikoff B. Does methotrexate confer a significant advantage over misoprostol alone for early medical abortion? A retrospective analysis of 8678 abortions. Int J Obstet Gynaecol. 2007;114(5):555-62.